Livzon Gains Control of Vietnam's Imexpharm in RMB 1.56 Billion Tender Offer

TipRanksApr 29 21:21

Livzon Pharmaceutical Clarifies Independence of Key Board Directors

TipRanksApr 28 17:19

Livzon Group (000513): Performance in Line with Expectations, Profitability Remains Stable

The Q1 2026 earnings report met our expectations. The company announced its Q1 2026 performance: operating revenue of 2.871 billion yuan, a year-on-year decrease of 9.73%; net profit attributable to shareholders of 577 million yuan, a year-on-year decrease of 9.39%; non-recurring net profit...

CICCApr 25 16:16

Is the 'first approval' for domestically produced semaglutide delayed? Multiple applicant companies claim there is a data protection period even after the patent cliff.

① Following the patent cliff, a heated competition among domestic manufacturers of Semaglutide over “who can obtain the first approval” has fallen into an unusual silence; ② Companies such as Jiuyuan Gene and Lizhu Group have indicated that the core reason for not obtaining the approval is related to the China-Switzerland Free Trade Agreement, with relevant data still under protection; ③ The extension of the protection period for Semaglutide may further intensify the “internal competition” among domestic manufacturers.

cls.cnApr 25 11:34

Livzon Pharmaceutical Issues Revised Proxy Form for 2025 AGM

TipRanksApr 24 21:39

Hong Kong Stock Announcements | China Telecom's Q1 net profit decreased by 17.1% year-on-year; Botech Auto Networking has reached a series of in-depth collaborations with a leading new energy vehicle manufacturer and NVIDIA.

AI Empowers Regional Drug Discovery: Insilico Medicine (03696) UAE Team Nominates First Preclinical Candidate Drug

Zhitong FinanceApr 24 08:59